Seeking Alpha

Swiss drugmaker Roche (RHHBY.PK), in a new letter to Illumina (ILMN) shareholders a week ahead...

Swiss drugmaker Roche (RHHBY.PK), in a new letter to Illumina (ILMN) shareholders a week ahead of a shareholders meeting for the maker of genetic analysis equipment, appears to indicate a willingness to raise its $51/share offer. ILMN shares, -1.6% AH, have been trading above $51 and closed at $52.57 today.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs